Yale Duan

706 total citations
17 papers, 554 citations indexed

About

Yale Duan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yale Duan has authored 17 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yale Duan's work include Neuroscience and Neuropharmacology Research (5 papers), Diabetes Treatment and Management (5 papers) and Diabetes Management and Research (4 papers). Yale Duan is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Diabetes Treatment and Management (5 papers) and Diabetes Management and Research (4 papers). Yale Duan collaborates with scholars based in China, United States and Netherlands. Yale Duan's co-authors include Suzhen Dong, Yinghe Hu, Zheng Zhao, Qingwen Zeng, Xiaohua Cao, Gang Wang, Jyoti Kumar Tiwari, Ellen Siobhan Mitchell, Chunxia Li and Li Zhang and has published in prestigious journals such as PLoS ONE, Neuroscience and European Journal of Pharmacology.

In The Last Decade

Yale Duan

16 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yale Duan China 11 197 185 130 102 92 17 554
Faheem Ullah Australia 10 183 0.9× 167 0.9× 105 0.8× 96 0.9× 73 0.8× 21 603
Preeti Dohare United States 17 267 1.4× 90 0.5× 185 1.4× 144 1.4× 53 0.6× 27 740
André Meneghetti Brazil 6 76 0.4× 198 1.1× 60 0.5× 96 0.9× 70 0.8× 8 412
Siamak Beheshti Iran 13 208 1.1× 148 0.8× 140 1.1× 34 0.3× 84 0.9× 34 577
N. Rajasekar India 10 153 0.8× 192 1.0× 105 0.8× 22 0.2× 75 0.8× 11 460
Phullara B. Shelat United States 9 380 1.9× 330 1.8× 170 1.3× 112 1.1× 96 1.0× 9 904
Kiran Kumar Akula India 14 162 0.8× 146 0.8× 197 1.5× 87 0.9× 63 0.7× 20 589
Amin Mokhtari‐Zaer Iran 12 207 1.1× 71 0.4× 71 0.5× 61 0.6× 50 0.5× 21 639
Pil‐Jae Kong South Korea 9 169 0.9× 79 0.4× 79 0.6× 77 0.8× 54 0.6× 11 482
Tianfang Jiang China 9 305 1.5× 302 1.6× 166 1.3× 55 0.5× 138 1.5× 15 1.0k

Countries citing papers authored by Yale Duan

Since Specialization
Citations

This map shows the geographic impact of Yale Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yale Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yale Duan more than expected).

Fields of papers citing papers by Yale Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yale Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yale Duan. The network helps show where Yale Duan may publish in the future.

Co-authorship network of co-authors of Yale Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Yale Duan. A scholar is included among the top collaborators of Yale Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yale Duan. Yale Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Zhang, Shuo, Rui Zuo, Yufei Hu, et al.. (2024). Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on “time in range” in patients with type 2 diabetes. Frontiers in Pharmacology. 15. 1370594–1370594. 1 indexed citations
3.
Cai, Hongyu, Qianqian Chen, Yale Duan, Yue Zhao, & Xiujuan Zhang. (2023). Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: An open-label, parallel-arm, randomized, metformin-controlled trial. Frontiers in Endocrinology. 14. 1106868–1106868. 13 indexed citations
4.
Zhang, Shuo, Zezhen Wu, Dan Zhu, et al.. (2023). Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial. Frontiers in Pharmacology. 14. 1171399–1171399. 3 indexed citations
5.
6.
Zhang, Guangming, Zelin Lai, Kejia Xu, et al.. (2021). Delta Opioid Receptor Activation with Delta Opioid Peptide [d-Ala2, d-Leu5] Enkephalin Contributes to Synaptic Improvement in Rat Hippocampus against Global Ischemia. Cell Transplantation. 30. 4211099441–4211099441. 5 indexed citations
7.
8.
Duan, Yanhong, Qi Wang, Qingwen Zeng, et al.. (2018). Striatal GluN2B involved in motor skill learning and stimulus-response learning. Neuropharmacology. 135. 73–85. 14 indexed citations
9.
Li, Ziyan, et al.. (2017). Xanomeline derivative EUK1001 attenuates Alzheimer's disease pathology in a triple transgenic mouse model. Molecular Medicine Reports. 16(5). 7835–7840. 7 indexed citations
10.
Wang, Shuyan, Yale Duan, Bing Zhao, et al.. (2016). Effect of delta opioid receptor activation on spatial cognition and neurogenesis in cerebral ischemic rats. Neuroscience Letters. 620. 20–26. 17 indexed citations
11.
Jia, Tao, Li Zhang, Yale Duan, et al.. (2014). The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway. Cancer Cell International. 14(1). 126–126. 90 indexed citations
12.
Duan, Yale, Rui Zhang, Min Zhang, et al.. (2013). Metformin inhibits food intake and neuropeptide Y gene expression in the hypothalamus.. PubMed. 8(25). 2379–88. 20 indexed citations
13.
Dong, Suzhen, Qingwen Zeng, Ellen Siobhan Mitchell, et al.. (2012). Curcumin Enhances Neurogenesis and Cognition in Aged Rats: Implications for Transcriptional Interactions Related to Growth and Synaptic Plasticity. PLoS ONE. 7(2). e31211–e31211. 139 indexed citations
14.
Dong, Suzhen, et al.. (2012). Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis. Translational Neurodegeneration. 1(1). 18–18. 103 indexed citations
15.
Duan, Yale, et al.. (2012). Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration. Translational Neurodegeneration. 1(1). 24–24. 58 indexed citations
16.
17.
Wang, Shuyan, Yale Duan, Diansan Su, et al.. (2011). Delta opioid peptide [d-Ala2, d-Leu5] enkephalin (DADLE) triggers postconditioning against transient forebrain ischemia. European Journal of Pharmacology. 658(2-3). 140–144. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Faheem Ullah Breakdown of academic impact, for papers by Preeti Dohare Breakdown of academic impact, for papers by André Meneghetti Breakdown of academic impact, for papers by Siamak Beheshti Breakdown of academic impact, for papers by N. Rajasekar Breakdown of academic impact, for papers by Phullara B. Shelat Breakdown of academic impact, for papers by Kiran Kumar Akula Breakdown of academic impact, for papers by Amin Mokhtari‐Zaer Breakdown of academic impact, for papers by Pil‐Jae Kong Breakdown of academic impact, for papers by Tianfang Jiang
Rankless by CCL
2026